CAP1400
CAP1400 is a type of Generation III nuclear reactor technology developed in China. It is an advanced pressurized water reactor (PWR) with a power output of 1400 MWe, hence the name CAP1400. The technology is based on the AP1000 reactor design by Westinghouse Electric Company, but with modifications to increase the power output and incorporate Chinese nuclear technology standards and regulations.
Development[edit | edit source]
The development of the CAP1400 technology began in 2008 as part of China's strategy to increase its domestic nuclear power capacity and reduce its reliance on fossil fuels. The project is led by the State Nuclear Power Technology Corporation (SNPTC), a subsidiary of the China National Nuclear Corporation (CNNC).
The design of the CAP1400 reactor incorporates passive safety features from the AP1000 design, which rely on natural forces such as gravity and convection, rather than mechanical systems, to maintain safety in the event of an emergency. These features include a passive cooling system, a core catcher to contain molten fuel in the event of a severe accident, and a containment structure designed to withstand a direct aircraft impact.
Construction[edit | edit source]
The first CAP1400 reactor is currently under construction at the Shidaowan Nuclear Power Plant in Shandong province. The construction began in 2014 and the reactor is expected to start operation in 2021. Once completed, it will be the largest PWR in China and one of the largest in the world.
Future Plans[edit | edit source]
China plans to build more CAP1400 reactors in the future as part of its goal to increase its nuclear power capacity. The technology is also being marketed for export to other countries, with potential customers including South Africa, Turkey, and Argentina.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD